Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of A2 Milk Versus Conventional Milk on Intestinal Health: a Proof-of-concept Study in Irritable Bowel Syndrome Patients

NCT04598529 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT04598529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04598529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of A2 Milk Versus Conventional Milk on Intestinal Health: a Proof-of-concept Study in Irritable Bowel Syndrome Patients
Lead sponsor
Maastricht University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
August 8, 2022
Completion date
June 5, 2023
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome